| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 54.44M | 45.31M | 36.81M | 32.33M | 29.36M |
| Gross Profit | 54.44M | 45.31M | 36.81M | 32.33M | 29.36M |
| EBITDA | 26.64M | 22.85M | 18.47M | 17.78M | 12.54M |
| Net Income | 18.84M | 16.14M | 12.99M | 9.24M | 6.11M |
Balance Sheet | |||||
| Total Assets | 68.22M | 62.44M | 52.46M | 51.95M | 41.35M |
| Cash, Cash Equivalents and Short-Term Investments | 35.12M | 33.25M | 24.94M | 26.62M | 21.86M |
| Total Debt | 631.00K | 848.00K | 659.00K | 268.00K | 539.00K |
| Total Liabilities | 13.18M | 11.89M | 9.13M | 10.16M | 10.30M |
| Stockholders Equity | 55.06M | 50.59M | 43.28M | 41.78M | 31.04M |
Cash Flow | |||||
| Free Cash Flow | 22.88M | 18.25M | 13.66M | 12.91M | 13.35M |
| Operating Cash Flow | 23.62M | 18.75M | 14.02M | 13.23M | 13.64M |
| Investing Cash Flow | -4.72M | -1.00M | -1.55M | -470.00K | -3.11M |
| Financing Cash Flow | -17.16M | -10.47M | -14.12M | -7.98M | -5.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £436.47M | 24.00 | 31.92% | 3.21% | 20.14% | 15.61% | |
79 Outperform | £780.07M | 20.55 | 30.00% | 8.73% | 7.71% | -7.39% | |
74 Outperform | £825.12M | 7.98 | 11.49% | 2.70% | 16.37% | 58.77% | |
72 Outperform | £193.00M | 29.53 | 4.43% | 5.14% | 1.02% | -62.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £173.97M | 1,641.05 | 10.12% | 21.31% | -20.90% | -40.53% | |
67 Neutral | £1.67B | 13.85 | 8.33% | 4.91% | 2.02% | 69.06% |